Induced sputum-retrieved matrix metalloproteinase 9 and tissue metalloproteinase inhibitor 1 in granulomatous diseases

Clinical and Experimental Immunology

Volumn 130, Issue 2, 2002, Pages 331-337

  Fireman, E ^a,e   Kraiem, Z ^b   Sade, O ^b   Greif, J ^a   Fireman, Z ^c,d  

^a TEL AVIV UNIVERSITY   (Israel)

^b CARMEL MEDICAL CENTER   (Israel)

^c HILLEL YAFFE MEDICAL CENTER   (Israel)

^d TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^e TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

Author keywords

Crohn's disease; Induced sputum; MMP 9; Sarcoidosis; TIMP1

Indexed keywords

GELATINASE; GELATINASE B; MONOCLONAL ANTIBODY; TISSUE INHIBITOR OF METALLOPROTEINASE 1;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CROHN DISEASE; CYTOTOXIC T LYMPHOCYTE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLUORESCENCE ACTIVATED CELL SORTING; HELPER CELL; HUMAN; LUNG PARENCHYMA; MALE; MOLECULAR WEIGHT; PRIORITY JOURNAL; SARCOIDOSIS; SPUTUM ANALYSIS; SUPERNATANT; T LYMPHOCYTE SUBPOPULATION; ZYMOGRAPHY;

ADULT; AGED; BIOLOGICAL MARKERS; CROHN DISEASE; DEMOGRAPHY; FEMALE; GELATIN; HUMANS; LEUKOCYTE COUNT; LUNG; MALE; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; RESPIRATORY FUNCTION TESTS; SARCOIDOSIS, PULMONARY; SPUTUM; TISSUE INHIBITOR OF METALLOPROTEINASE-1;

EID: 0036408395     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.2002.t01-1-02001.x     Document Type: Article

References (42)

1. Hotermans G, Benard A. Nongranulomatous interstitial lung disease in Crohn's disease. Eur Respir J 1996; 9:380-8.
2. Fellermann K, Stahl M, Dahlhoff K et al. Crohn's disease and sarcoidosis: Systemic granulomatosis? Eur J Gastroenterol Hepatol 1997; 9:1121-4.
3. Lamblin C, Copin M, Billaut C. Acute respiratory failure due to tracheobronchial involvement in Crohn's disease. Eur Respir J 1996; 9:2176-8.
4. Bonniere P, Wallaert B, Cortot A et al. Latent pulmonary involvement in Crohn's disease, biological, functional, bronchoalveolar lavage and scintigraphic studies. Gut 1986; 27:919-25.
5. Johard U, Berlin M, Eklund A. Sarcoidosis and regional enteritis in two patients. Sarcoidosis Vasc Diffuse Lung Dis 1996; 13:50-3.
6. Hunninghake GW, Crystal RG. Pulmonary sarcoidosis a disorder mediated by excess helper T-lymphocyte activity at sites of disease activity. N Engl J Med 1981; 305:429-34.
7. Fireman EM, Topilsky MR. Sarcoidosis: An organized pattern or reaction from immunology to therapy. Immunol Today 1994; 15:199-201.
8. Newman LS, Cecile RS, Maier LA. Sarcoidosis. N Engl J Med 1997; 17:1224-5.
9. Docherty AJP, Murphy G. The tissue metalloproteinase family and the inhibitor TIMP. A study using cDNAs a recombinant proteins. Ann Rheum Dis 1990; 49:469-79.
10. Brown CC, Hembry RM, Reynolds JJ. Immunolocalization of metalloproteinases and their inhibitor in the rabbit growth plate. J Bone Joint Surg 1989; 71-A:580-93.
11. Gravallese EM, Darling JM, Ladd AL et al. In situ hybridization studies of stromelysin and collagenase messenger RNA expression in rheumatoid synovium. Arthritis Rheum 1992; 34:1076-84.
12. Murphy G, Docherty AJP. The matrix metalloproteinases and their inhibitors. Am J Respir Cell Mol Biol 1992; 7:120-5.
13. Kornbluth A, Sachar D, Salomon P. Crohn's disease. In: Sleisenger, MN, Fordtran, JS, eds. Gastrointestinal and Liver Diseases, 6th Edn. Philadelphia: W.B. Saunders, 1998:1708-34.
14. Best WR, Beckler JM. Development of a Crohn's Disease Activity Index: National Cooperative Crohn's Disease Study Gastroenterol 1976; 70:439-46.
15. American Thoracic Society (statement). Standardization of spirometry-1987. Update. Am Rev Respir Dis 1987; 136:1285-98.
16. Pin I, Gibson PG, Kolendovich R et al. Use of induced sputum cell counts to investigate airway inflammation in asthma. Thorax 1992; 47:25-9.
17. Popov T, Gottschalk R, Kolendowich R et al. The evaluation of a cell dispersion method of sputum examination. Clin Exp Allergy 1994; 24:778-83.
18. Kleiner DE, Stetler-Stevenson WG. Quantitative zymography: Detection of picogram quatities of gelatinases. Ann Biochem 1994; 218:325-9.
19. Muler S, Lory J, Corazza N et al. Activated CD4 and CD8 cytotoxic cells are present in increased numbers in the intestinal mucosa from patients with active inflammatory bowel disease. Am J Pathol 1998; 152:261-8.
20. Hayashi T, Stetler-Stevenson WG, Fleming MV et al. Immunohistochemical study of metalloproteinases and their tissue inhibitor in the lungs of patients with diffuse alveolar damage in idiopathic pulmonary fibrosis. Am J Pathol 1996; 149:1241-56.
21. Ricou B, Nicod L, Lacraz S et al. Matrix metalloproteinase and TIMP in acute respiratory distress syndrome. Am J Respir Crit Care Med 1996; 154:346-52.
22. Finlay GA, O'Driscoll LR, Russel KJ et al. Matrix metalloproteinase expression and production by alveolar macrophages in emphysema. Am J Respir Crit Care Med 1997; 156:240-7.
23. Suga M, Iyonaga K, Okamoto T et al. Characteristic elevation of matrix metalloproteinase activity in idiopathic interstitial pneumonias. Am J Respir Crit Care Med 2000; 162:1949-56.
24. Pardo A, Barrios R, Gaxiola M et al. Increase of lung neutrophils in hypersensitivity pneumonitis is associated with lung fibrosis. Am J Respir Crit Care Med 2000; 161:1698-704.
25. Madtes DK, Elston AL, Kaback LA. et al. Selective induction of tissue inhibitor of metalloproteinase-1 in bleomycin-induced pulmonary fibrosis. Am J Respir Cell Mol Biol 2001; 24:599-607.
26. Fireman Z, Osipov A, Kivity S et al. The use of induced sputum in the assessment of pulmonary involvement in Crohn's disease. Am J Gastroenterol 2000; 95:730-4.
27. Fireman E, Topilsky I, Greif J et al. Evaluation of interstitial lung diseases by induced sputum compared to bronchoalveolar lavage. Respir Med 1999; 93:827-34.
28. D'Ippolito R, Foresi A, Chetta A et al. Induced sputum in patients with newly diagnosed sarcoidosis. Chest 1999; 115:1611-5.
29. Moodley YP, Dorasamy T, Venketasamy S et al. Correlation of CD4/CD8 ratio and TNFα levels in induced sputum with bronchoalveolar lavage fluid in pulmonary sarcoidosis. Thorax 2000; 55:696-9.
30. Fireman E, Vardinon N, Burke M et al. The prognostic and diagnostic value of T-lymphocytes subtypes analysis in idiopathic pulmonary fibrosis. Eur Respir J 1998; 11:706-11.
31. Yamadori I, Fujita J, Kajitani H et al. Lymphocyte subsets in tissues of non specific interstitial pneumonia and pulmonary fibrosis associated with collagen vascular disorders: Correlation with CD4/CD8 ratio in bronchoalveolar lavage. Lung 2000; 178:361-70.
32. Atamas SP, Yurovsky VV, Wise R et al. Production of type 2 cytokines by CD8 lung cells is associated with greater decline in pulmonary function in patients with systemic sclerosis. Arthritis Rheum 1999; 43:1168-78.
33. Domagala-Kulawik J, Hoser G, Doboszynska A et al. Interstitial lung diseases in systemic sclerosis. Comparison of BALF lymphocyte phenotype and DLCO impairment. Respir Med 1998; 92:1295-301.
34. Vignola AM, Riccobono L, Mirabella A et al. Sputum metalloproteinase-9 tissue inhibitor of metalloproteinase-1 ratio correlates with air-flow obstruction in asthma and chronic bronchitis. Am J Respir Crit Care Med 1998; 158:1945-50.
35. Stockley RA, Bayley DL. Validation of assays for inflammatory mediators in sputum. Eur Respir J 2000; 15:778-81.
36. Jackson CJ, Arkell J, Nguyen M. Rheumatoid synovial endothelial cells secrete decreased levels of tissue inhibitor of MMP (TIMP1). Ann Rheum Dis 1998; 57:158-61.
37. Perez-Ramoz J, de Lourdes Segura-Valdez M, Vanda B et al. Matrix metalloproteinase 2, 9, and 13 and tissue inhibitors of metalloproteinase 1 and 2 in experimental lung silicosis. Am J Respir Crit Care Med 1999; 160:1274-82.
38. Corbel M, Lagente V, Boichot E. Pulmonary inflammation and tissue remodelling: Role of metalloproteinase. Eur Respir Rev 2000; 10:260-3.
39. American Association for Respiratory Care Clinical Practice Guidelines. Single breath carbon monoxide diffusing capacity. Respir Care 1993; 38:511-5.
40. Corbel M, Caulet-Maugendre S, Germain N et al. Inhibition of bleomycin-induced pulmonary fibrosis in mice by the matrix metalloproteinase inhibitor batismat. J Pathol 2001; 193:538-45.
41. Opdenaker G, Van den Steen PE, Damme JV, Gelatinase B. A tuner and amplifier of immune functions. Trends Immunol 2001; 22:527-81.
42. Camus Ph, Colby TV. The lung in inflammatory bowel disease. Eur Respir J 2000; 15:5-10.